MedAlerts Home
  Read the MedAlerts Blog Subscribe to the MedAlerts Blog 

Found 958 cases where Vaccine is VARZOS and Serious

Case Details

This is page 14 out of 96

Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23   next


VAERS ID:299782 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Male  Submitted:2007-12-13
Location:Colorado  Entered:2007-12-14, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0712USA02139
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Herpes zoster, Post herpetic neuralgia
SMQs:
Write-up: Information has been received from a physician concerning a male patient who was vaccinated with a single dose of Zostavax. Subsequently, one month post vaccination, the patient developed shingles and post herpetic neuralgia. Unspecified medical attention was sought and the patient was hospitalized for an unspecified amount of time. No outcomes were reported. No product quality complaint was involved. Additional information has been requested.

VAERS ID:299784 (history)  Vaccinated:2007-12-01
Age:83.0  Onset:0000-00-00
Gender:Male  Submitted:2007-12-13
Location:Massachusetts  Entered:2007-12-14, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0712USA02158
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC. 0UNUN
Administered by: Other     Purchased by: Other
Symptoms: Herpes zoster, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: Information has been received from a physician concerning an 83 year old male who, "sometime last week", on approximately 01-DEC-2007, was vaccinated with a first dose of zoster vaccine live (Oka/Merck). Subsequently the patient developed a 4 to 5 inch radius rash which appeared to be a case of shingles. The patient was hospitalized but the specifics were unknown. No product quality complaint was involved. No other information was provided. Additional information has been requested.

VAERS ID:300081 (history)  Vaccinated:2007-11-28
Age:84.0  Onset:2007-12-03, Days after vaccination: 5
Gender:Male  Submitted:2007-12-14, Days after onset: 11
Location:Unknown  Entered:2007-12-17, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Type 2 diabetes mellitus
Preexisting Conditions:
Diagnostic Lab Data: wound culture
CDC 'Split Type': WAES0712USA01645
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC. 0SCUN
Administered by: Other     Purchased by: Other
Symptoms: Culture wound, Herpes zoster, Pain, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: Information has been received from a health professional concerning an 84 year old male patient with type 2 diabetes mellitus who on 28-NOV-2007 was vaccinated with zoster vaccine live (Oka/Merck), 0.65 ml subcutaneously in left deltoid. On 03-DEC-2007 the patient notified the physician of a painful rash on the left side of the chest. On 04-DEC-2007, the patient was admitted to the hospital via the emergency room for treatment of the shingles and pain control. The patient is incapacitated by the shingles pain. The patient continues to be hospitalized and received 1 gram of VALTREX three times daily (route unspecified). The health care professional is interested in VZV analysis by PCR. No other symptoms were reported. The event of the patient developed shingles after zoster vaccine persisted, was considered to be disabling. Additional information was received via a telephone call on 06-DEC-2007 from the nurse. The nurse indicated that the patient was still hospitalized for pain control. The nurse explained that the physician was thinking that the patient might have been on the verge of getting shingles prior to vaccination since he developed shingles so quickly after vaccination. She reported that the patient had a wound culture done at the hospital, however did not have any results. She stated the plan was to possibly discharge him from the hospital on 06-DEC-2007. The VZVIP program was discussed, and she indicated she would discuss sending a specimen with the physician. No further information is available.

VAERS ID:300082 (history)  Vaccinated:2007-05-21
Age:73.0  Onset:2007-05-21, Days after vaccination: 0
Gender:Female  Submitted:2007-12-14, Days after onset: 207
Location:Unknown  Entered:2007-12-17, Days after submission: 3
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Zoloft
Current Illness: Urinary tract infection
Preexisting Conditions: Lung neoplasm malignant
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0712USA01656
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0623F UNUN
Administered by: Other     Purchased by: Other
Symptoms: Activities of daily living impaired, Aphasia, General physical health deterioration, Immunisation reaction, Rash, Systemic lupus erythematosus rash, Weight decreased
SMQs:, Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Systemic lupus erythematosus (narrow), Dementia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Hypersensitivity (narrow)
Write-up: Information has been received from a consumer concerning her 73-year-old mother who has constant urinary tract infections and a history of lung cancer in 2005 (at that time she had about 16 to 18 chemo sessions) who on 21-May-2007 was vaccinated with a dose of zoster vaccine live (Oka/Merck) (lot #652966/0623F). The daughter seems to think that the physician did not tell her mother she should not get the shot. The patient''s cancer is now in remission. Concomitant therapy included sertraline HC1 (Zoloft). Around late June or July the patient developed a rash that "kept growing up her arm". She went to the dermatologist and they thought she was having a reaction to the vaccine. They did a biopsy and found out that it was lupus. The physician gave the patient medication that would make her get severe headaches, nausea and diarrhea (medication was not specified). The patient has been deteriorating ever since. The patient has been in and out of the hospital weeks at a time. She was doing okay and feeding herself and walking and talking and now has lost a lot of weight, can not feed herself and does not talk. At the time of the report the patient''s status was not recovered. A product quality complaint was not involved. No further information is available.

VAERS ID:300084 (history)  Vaccinated:2007-10-01
Age:  Onset:0000-00-00
Gender:Male  Submitted:2007-12-14
Location:Michigan  Entered:2007-12-17, Days after submission: 3
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Therapy unspecified
Current Illness: Coronary disease
Preexisting Conditions:
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0712USA02383
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Rhabdomyolysis
SMQs:, Rhabdomyolysis/myopathy (narrow), Neuroleptic malignant syndrome (broad)
Write-up: Information has been received from a physician concerning a male with coronary disease who "about two months ago (approx October 2007), was vaccinated with Zostavax. Concomitant therapy included a "Statin". The patient developed rhabdomolysis. Laboratory and diagnostics studies were not reported. It was reported that no medical attention was sought by the patient. A product quality complaint was not reported. Rhabdomyolysis was considered by the reporting physician to be life threatening. Additional information has been requested.

VAERS ID:301093 (history)  Vaccinated:2007-11-29
Age:75.0  Onset:2007-11-29, Days after vaccination: 0
Gender:Female  Submitted:2007-12-26, Days after onset: 27
Location:New York  Entered:2007-12-27, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: VICODIN; ULTRACET; aspirin; calcium (unspecified); MONOPRIL; hydrochlorothiazide; vitamins (unspecified)
Current Illness: Drug hypersensitivity
Preexisting Conditions: Back pain
Diagnostic Lab Data: computed axial 12/11/07 - negative
CDC 'Split Type': WAES0712USA07916
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0966U SCUN
Administered by: Other     Purchased by: Other
Symptoms: Blood pressure increased, Computerised tomogram normal, Headache
SMQs:, Neuroleptic malignant syndrome (broad), Hypertension (narrow)
Write-up: Information has been received from a healthcare worker concerning a 75-year-old female with a history of "treatment back pain stenosis", an allergy to CARDIZEM and LOPRESSOR who on 29-NOV-2007 was vaccinated subcutaneous in the left arm with a 0.5 ml dose of Zostavax (lot # 658395/0966U). Concomitant therapy included hydrochlorothiazide (manufacturer unspecified), MONOPRIL, aspirin, VICODIN, ULTRACET, multi-vitamins (unspecified) and calcium (unspecified). On 11-DEC-2007 the patient called the "office" and reported that she had a headache since 09-DEC-2007. The headache was described as a 9 out of 10 and intolerable. The patient also reported that her blood pressure was elevated. The patient went to the emergency room and was released with a negative CAT scan on 11-DEC-2007. As of 17-DEC-2007 the patient still had a headache which has lessened but is still intolerable. At the time of the report the patient''s status was recovering. A product quality complaint was not involved. The adverse events reported were considered to be disabling by the reporter. Additional information has been requested.

VAERS ID:301094 (history)  Vaccinated:2007-10-23
Age:73.0  Onset:2007-11-27, Days after vaccination: 35
Gender:Female  Submitted:2007-12-26, Days after onset: 29
Location:Unknown  Entered:2007-12-27, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: drug hypersensitivity
Preexisting Conditions:
Diagnostic Lab Data: None
CDC 'Split Type': WAES0712USA08100
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Trigeminal neuralgia
SMQs:, Demyelination (broad)
Write-up: Information has been received from a retired physician concerning his 73 year old wife with a codeine allergy and no other pertinent medical history who on approximately 23-OCT-2007 "6-8 weeks ago," was vaccinated with one dose of Zostavax (Oka/Merck). On approximately 27-NOV-2007 "3 weeks ago," the patient experienced trigeminal neuralgia. The trigeminal neuralgia was misdiagnosed as a dental problem. Medical attention was sought by contacting her primary care physician. No labs or diagnostic studies were performed. The patient''s trigeminal neuralgia persisted. There was no product quality complaint. Trigeminal neuralgia was considered to be disabling by the physician. Additional information has been requested.

VAERS ID:301273 (history)  Vaccinated:2007-10-31
Age:61.0  Onset:2007-11-21, Days after vaccination: 21
Gender:Female  Submitted:2007-12-31, Days after onset: 40
Location:California  Entered:2007-12-31
Life Threatening? Yes
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No
Preexisting Conditions: Bipolar, Neuropathic pain syndrome, DJD, HTN, DM, High Chol, S/P Melanoma. PMH: Chronic Pain syndrome, Group A strep bacteremia, anemia, DJD, HTN, hypothyroidism, Bipolar Disorder, PE 1999, melanoma, neurogenic bladder, gallstones, CHF 1999 s/p cardiac cath, irritable bowel syndrome, hernia repair, bilateral knee replacements, hysterectomy, umbilical hernia repair, basal cell carcinoma, prominant adrenal nodule, recent falls due to Flexeril. Allergies: Scopolamine and corn.
Diagnostic Lab Data: CXR pulm congestion; CBC, ESR, Renal function, LFT''s NL. Labs and Diagnostics: CMP with low Ca 8.3, Protein 5.5, and globulin 1.8. UA Cloudy with 1+ leukocyte esterase, 6-10 WBCs, 6-10 epi, few bacteria and few Ca oxylate crystals. Echocardiogram 1/7/2008 with mild L ventricular enlarement with normal systolic function, Mild impairment of diastolic function. Mild to moderate mitral regurg. Mild tricuspid regurg. PAP upper limit of normal. CXR shows Asymmetric mild CHF. May be related to positioning with R dependant edema vs asymmetric emphysema in the L lung. Increased density in R lung base./
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0966U0SCLA
Administered by: Private     Purchased by: Private
Symptoms: Blood calcium decreased, Cardiac failure congestive, Chest X-ray abnormal, Echocardiogram abnormal, Fluid retention, Full blood count, Globulins decreased, Liver function test normal, Metabolic function test, Protein total decreased, Pulmonary congestion, Red blood cell sedimentation rate normal, Renal function test, Swelling, Urine analysis abnormal, Weight increased, White blood cell count
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (narrow), Anaphylactic reaction (broad), Angioedema (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Tumour lysis syndrome (broad)
Write-up: Congestive heart failure, fluid retention (20 lb wt gain 6 wk after vaccination). 01/10/2008 MR records received from PCP, including several f/u visits to pain specialist and hospital D/c Summary from 8/27/07 for Intractable recurrent tension headaches (prior to vax). Pt seen 10/31/2007 for Zostavax due to family member with shingles. Wt 143. OV 12/19/2007 with c/o of swelling and wt gain. Wt now 164. Feels fine. Seen again 12/21/07 Wt 169.5. Weight decreased with lasix. Down to 151 in 1/4/08. Per 60 day follow up: Continued fluid retention of new onset requiring salt restriction plus LASIX 80 BID. Echocardiogram did not indicate cardiomyopathy. Endocrine consult pending.

VAERS ID:301352 (history)  Vaccinated:2007-12-10
Age:63.0  Onset:2007-12-17, Days after vaccination: 7
Gender:Female  Submitted:2008-01-02, Days after onset: 16
Location:North Carolina  Entered:2008-01-02
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No acute illnesses.
Preexisting Conditions: Has type 2 DM, hypertension, glaucoma, OA s/p TKR. 1/8/08-records received- PMH: Hypertension. Diabetes.
Diagnostic Lab Data: MRI normal. Audiogram confirmed clinical findings.
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.0162U0IMLA
Administered by: Unknown     Purchased by: Unknown
Symptoms: Audiogram abnormal, Deafness neurosensory, Deafness unilateral, Dizziness, Electrocardiogram abnormal, Faecal incontinence, Flatulence, Hypoacusis, Labyrinthitis, Nasal congestion, Nuclear magnetic resonance imaging normal, Vertigo
SMQs:, Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hearing impairment (narrow), Vestibular disorders (narrow), Noninfectious diarrhoea (broad)
Write-up: Patient developed profound sensorineural hearing loss and mild vertigo in the left ear one week after vaccination. This has persisted until today. MRI showed no tumor or stroke. 1/7/08-records received-office visit 12/17/07-developed acute onset of dizziness and vertigo/room spinning as well as hearing deficit that was worse on left and slightly decreased on right. Nasal congestion since onset of symptoms. Impression: labyrinthitis. Office visit 12/28/07-Left ear hearing loss. Vertigo symptoms intermittently. Impression:sudden sensory neural hearing loss with very little improvement. Per 60 day follow up: Permanent hearing loss. 1/15/2010 I don''t think her event was related. She had sudden sensorinearal hearing loss.

VAERS ID:302456 (history)  Vaccinated:0000-00-00
Age:79.0  Onset:0000-00-00
Gender:Male  Submitted:2007-12-21
Location:Unknown  Entered:2007-12-28, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Chemotherapy; Surgery; Splenic marginal zone lymphoma; Splenectomy; Anaemia; Thrombocytopenia
Diagnostic Lab Data: biopsy - negative; WBC count - Above 200,000; WBC count 05/??/07 - 20,000 to 30,000
CDC 'Split Type': WAES0710USA02759
Vaccination
Manufacturer
Lot
Dose
Route
Site
VARZOS: ZOSTER (ZOSTAVAX)MERCK & CO. INC.  UNUN
Administered by: Other     Purchased by: Other
Symptoms: Biopsy site unspecified normal, Immunosuppression, Medication error, Pruritus, Rash, White blood cell count increased
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Hypersensitivity (narrow)
Write-up: Information has been received from a pharmacist concerning her 79 year old father with a history of chemotherapy, surgery and splenic marginal zone lymphoma and splenectomy who in May 2007, was vaccinated with a dose of zoster vaccine live (Oka/Merck). In June 2007, (one month after vaccination) the patient developed a bilateral leg rash from the thigh to the ankle. The patient was seen by dermatologist who prescribed an unspecified steroid cream for the rash. The physician also performed a biopsy (type unspecified) that was reported to be negative. The rash was concentrated in the right lower leg. At the time of the report the patient had not recovered. No further information was provided. There was no product quality complaint involved. Additional information has been received from the pharmacist who stated that the patient had splenic marginal zone lymphoma treated in the past with chemotx and a subsequent splenectomy. The pharmacist reported that prior to the splenectomy the patient''s WBC count ran consistently above 200,000 and he was anemic and thrombocytopenic. Post splenectomy the patient is no longer anemic or thrombocytopenic and his WBC count ran generally in 20-30,000 range. The pharmacist reported that her father was immunocompromised. It was also reported that the patient developed a rash on both legs within 1 month post-vaccination. The rash on both legs from the thighs to ankles, and front to back of each leg. It was reported that at present the rash persisted on a small area of the right leg only. The patient continued to experience significant itching both in places where the rash as well as other areas of the body in which there was no rash. The patient never had any past skin issues.

Result pages: prev   5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23   next

New Search

Link To This Search Result:
http://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=14&VAX[]=VARZOS&SERIOUS=ON


Copyright © 2014 National Vaccine Information Center. All rights reserved.
407-H Church Street, Vienna, Virginia 22180